Correlation Between Samsung Biologics and Doosan Solus

Can any of the company-specific risk be diversified away by investing in both Samsung Biologics and Doosan Solus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Samsung Biologics and Doosan Solus into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Samsung Biologics Co and Doosan Solus Co, you can compare the effects of market volatilities on Samsung Biologics and Doosan Solus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Samsung Biologics with a short position of Doosan Solus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Samsung Biologics and Doosan Solus.

Diversification Opportunities for Samsung Biologics and Doosan Solus

0.49

Correlation Coefficient

Samsung Biologics  Doosan Solus

Very weak diversification

The 3 months correlation between Samsung and Doosan is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Samsung Biologics Co and Doosan Solus Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Doosan Solus and Samsung Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Samsung Biologics Co are associated (or correlated) with Doosan Solus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Doosan Solus has no effect on the direction of Samsung Biologics i.e., Samsung Biologics and Doosan Solus go up and down completely randomly.

Pair Corralation between Samsung Biologics and Doosan Solus

Assuming the 90 days trading horizon Samsung Biologics Co is expected to generate 0.22 times more return on investment than Doosan Solus. However, Samsung Biologics Co is 4.54 times less risky than Doosan Solus. It trades about 0.18 of its potential returns per unit of risk. Doosan Solus Co is currently generating about 0.02 per unit of risk. If you would invest  93,700,000  in Samsung Biologics Co on December 25, 2024 and sell it today you would earn a total of  6,300,000  from holding Samsung Biologics Co or generate 6.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.25%
Values	Daily Returns

Samsung Biologics Co  vs.  Doosan Solus Co

Samsung Biologics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Samsung Biologics Co are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Samsung Biologics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Doosan Solus

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Doosan Solus Co are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Doosan Solus is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Samsung Biologics and Doosan Solus

The main advantage of trading using opposite Samsung Biologics and Doosan Solus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Samsung Biologics position performs unexpectedly, Doosan Solus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Doosan Solus will offset losses from the drop in Doosan Solus' long position.

The idea behind Samsung Biologics Co and Doosan Solus Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.